About Fitzsimons Innovation Community

Innovation is happening. Right here.

Fitzsimons Innovation Community is a sprawling campus of leading-edge laboratory workspace where innovative health and life sciences companies of all sizes take their research to the next level to cure diseases, save lives, and improve care.

Smart, inclusive, forward-thinking, and highly educated people lead life sciences innovation in Colorado, the Hub for Health Impact. Together, we welcome life sciences organizations looking to call Colorado home and to collaborate with a robust community already in on the secret: the health and life sciences industry in Colorado is strong and making a global impact on the future of health.

Move in, and build your vision here—today.

Two individuals working in a laboratory

The emphasis is on Community

We called it a community for a reason. From the board of directors to the newest company on campus, everyone at Fitzsimons Innovation Community knows that easy access to collaboration has direct results on success. From idea incubation to final-product manufacturing, your end-to-end innovation can come alive right here on our campus. All that Colorado sunshine is just a bonus.

Community

Cutting-edge discoveries in action

$72M

Capital Raised

Last year, Fitzsimons Innovation Community member companies attracted more than $72M in investments to support R&D, prepare for clinical trials, accelerate commercialization, retain or recruit talent, and expand to new markets.

50%

Companies Fundraising

Fitzsimons Innovation Community member companies are actively involved in fundraising to power their progress.

30%

Companies Launching New Products

Fitzsimons Innovation Community member companies are launching new products and solutions to market.

*Fitzsimons Innovation Community Member Growth Survey responses (January – December 2024)

A blueprint for the next chapter of scientific development

The new Fitzsiomons Innovation Community Master Plan has been decades in the making, evolving with changing technology, people, and infrastructure and designed to meet the work-live-play needs of the modern life sciences professional. Explore our vision for the future.

 Fitzsimons Innovation Community Team

Our team is on
your team

You know best when it comes to your projects, and we know how to keep you up and running with first-class scientific facilities management and community engagement. Our priority is to help you thrive on this campus and we have the proven tools and expertise to make that happen.

Backed by excellence

Our Board of Directors is a group of leaders who are passionate about your goals and discoveries. Armed with serious business, legislative, and health sciences credentials, they know winning innovation inside and out, and they put our Community and its members at the heart of every strategic decision.

Board of Directors having a Board Meeting at the Fitzsimons Innovation Community campus

Meet our Community members

From early-stage founders to seasoned physicians and researchers, our Community brings together diverse talent united by a mission to transform the future of patient care. Explore our directory to connect with the people and expertise shaping life sciences innovation at Fitzsimons Innovation Community.

Community

Fitzsimons Innovation Community News

  • 3i Chooses Fitzsimons Innovation Community for New Headquarters

    Colorado-born microscopy company will bring manufacturing, research and customer demonstration capabilities closer to one of Colorado’s largest concentrations of biomedical researchers AURORA, Colo. – October 21, 2026 – Intelligent Imaging Innovations (3i), a Colorado-based developer and manufacturer of advanced microscopy systems, is relocating its headquarters to Bioscience 3 at Fitzsimons Innovation Community. The move is…
  • Intero Biosystems Wins Startup Battlefield at TechCrunch Disrupt 2026

    Intero Biosystems, a member of Fitzsimons Innovation Community, has been named the winner of Startup Battlefield at TechCrunch Disrupt 2026, earning national recognition for its innovative approach to biotechnology. The achievement highlights Intero’s growing presence in the life sciences industry and brings additional visibility to the innovative companies advancing scientific discovery and commercialization within Colorado’s…
  • Fitzsimons Innovation Community Welcomes Georgia Leadership Delegation

    Fitzsimons Innovation Community recently welcomed 47 business, civic and community leaders from Georgia as part of the Greater North Fulton Chamber of Commerce’s 2026 Strategic Leadership Visit to the Denver metropolitan area. The three-day visit provided opportunities for regional leaders to explore approaches to economic development, transportation, redevelopment and innovation. During their visit to Fitzsimons,…
  • Pathways Bioscience’s PB125 Shows Promising Results in Human Vascular Health Study

    Pathways Bioscience, a member of Fitzsimons Innovation Community, has announced the publication of new clinical research demonstrating that its proprietary botanical formulation, PB125, improved vascular function in older adults and helped preserve vascular function during periods of physical inactivity. The randomized, double-blind, placebo-controlled study, independently conducted by researchers affiliated with the University of Utah, Salt…
  • Children’s Hospital Colorado Recognizes Emerging Pediatric Researchers

    The Colorado Child Health Research Institute at Children’s Hospital Colorado has announced its spring 2026 research award recipients, recognizing early-career investigators advancing innovative approaches to pediatric health challenges. Supported in part by philanthropic investment, the awards provide funding for research addressing conditions including traumatic brain injury, chronic lung disease and other complex pediatric health concerns….
  • CU Anschutz Receives FDA Clearance for CAR T-Cell Cancer Therapy Trial

    The University of Colorado Anschutz has received clearance from the U.S. Food and Drug Administration (FDA) to begin a clinical trial investigating an experimental CAR T-cell therapy for adults with advanced colorectal cancer and pediatric patients with certain solid tumors. Developed by CU Anschutz researchers, the treatment uses genetically modified immune cells designed to target…
  • Fitzsimons Innovation Community Partners With Aurora Public Schools on Student Mural Project

    Fitzsimons Innovation Community is partnering with Aurora Public Schools and NINE dot ARTS to bring a collaborative public art project to its campus during the 2026-27 school year. The initiative will engage 12th-grade students from the Charles Burrell Visual & Performing Arts Campus in creating a mural that reflects Fitzsimons’ mission, values and connection to…
  • Cobio Diagnostics Secures $2.2 Million NIH Grant to Advance Rapid Infection Testing

    Cobio Diagnostics, a member of Fitzsimons Innovation Community, has received a $2.2 million Small Business Innovation Research (SBIR) Fast-Track grant from the National Institutes of Health (NIH) to advance its rapid diagnostic technology for urinary tract infections. The funding will support development of a diagnostic test designed to identify infection-causing bacteria directly from patient samples…
  • CU Anschutz SPARK Colorado Selects Nine Projects Advancing Medical Innovation and Patient Care

    CU Anschutz Innovations has announced nine faculty-led projects selected for the 2026 SPARK Colorado and digiSPARK programs, supporting the development and commercialization of emerging medical technologies. The projects span next-generation cell therapies, artificial intelligence, surgical devices, novel diagnostics and treatments for complex diseases. Since launching in 2018, SPARK Colorado has supported 70 projects, helped launch…
  • Andon Bio Founder Selected for Activate’s 2026 Fellowship Cohort

    Laura White, founder of Andon Bio and a member of Fitzsimons Innovation Community, has been selected for Activate’s 2026 fellowship cohort, joining 50 scientist-innovators working to translate scientific discoveries into commercially viable technologies. Andon Bio is developing a nanopore-based measurement platform designed to improve the predictability of protein production, an essential process in manufacturing biologic…